PEPE, MARTINO
 Distribuzione geografica
Continente #
NA - Nord America 6.295
AS - Asia 2.449
EU - Europa 2.258
SA - Sud America 551
AF - Africa 126
OC - Oceania 8
AN - Antartide 1
Totale 11.688
Nazione #
US - Stati Uniti d'America 6.186
SG - Singapore 1.025
IT - Italia 934
CN - Cina 439
BR - Brasile 418
DE - Germania 338
HK - Hong Kong 280
RU - Federazione Russa 223
FR - Francia 206
VN - Vietnam 178
FI - Finlandia 169
BD - Bangladesh 135
GB - Regno Unito 107
SE - Svezia 101
IN - India 78
CA - Canada 57
AR - Argentina 56
ID - Indonesia 50
NL - Olanda 40
IQ - Iraq 38
PK - Pakistan 37
CI - Costa d'Avorio 34
TR - Turchia 34
MX - Messico 28
JP - Giappone 25
ZA - Sudafrica 23
AT - Austria 21
CO - Colombia 20
EC - Ecuador 18
ES - Italia 17
TN - Tunisia 17
PH - Filippine 16
BE - Belgio 15
MA - Marocco 15
UZ - Uzbekistan 15
UA - Ucraina 14
VE - Venezuela 14
MY - Malesia 13
PL - Polonia 13
SA - Arabia Saudita 12
JO - Giordania 11
CZ - Repubblica Ceca 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
AU - Australia 8
PE - Perù 8
AZ - Azerbaigian 7
CH - Svizzera 7
EG - Egitto 7
IE - Irlanda 7
PY - Paraguay 7
CL - Cile 6
IL - Israele 6
KE - Kenya 6
DO - Repubblica Dominicana 5
JM - Giamaica 5
KZ - Kazakistan 5
IR - Iran 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
OM - Oman 3
PA - Panama 3
QA - Qatar 3
SC - Seychelles 3
TW - Taiwan 3
AL - Albania 2
BF - Burkina Faso 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CM - Camerun 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
Totale 11.670
Città #
Dallas 2.637
Singapore 550
Ashburn 459
San Jose 433
Milan 290
Hong Kong 277
Fairfield 223
Beijing 163
Munich 161
Helsinki 134
Chandler 133
Woodbridge 119
New York 113
Boardman 102
Houston 100
Rome 95
Columbus 92
Lauterbourg 90
Los Angeles 87
Council Bluffs 85
Bari 82
Falkenstein 81
Seattle 80
Cambridge 74
Nyköping 65
Wilmington 59
Santa Clara 56
Ho Chi Minh City 52
Buffalo 50
Ann Arbor 47
Hanoi 45
Jakarta 42
Abidjan 34
Marseille 34
Chicago 32
São Paulo 29
Naples 26
London 23
Xi'an 23
Frankfurt am Main 22
Tokyo 20
Turku 20
Baghdad 19
Lawrence 19
Montreal 19
Roxbury 19
Figino 18
Nuremberg 18
Atlanta 17
Brooklyn 17
Jacksonville 17
Turin 17
Nanjing 16
Rio de Janeiro 16
Poplar 15
Tashkent 15
Moscow 14
Denver 13
Manchester 13
Shenzhen 13
Brussels 12
Da Nang 12
Johannesburg 12
San Diego 12
Stockholm 12
Ankara 11
Des Moines 11
Karachi 11
Lahore 11
Salvador 11
Secaucus 11
The Dalles 11
Amman 10
Barletta 10
Florence 10
Mexico City 10
Phoenix 10
Salt Lake City 10
San Francisco 10
Charlotte 9
Orem 9
Paris 9
Toronto 9
Warsaw 9
Buenos Aires 8
Dong Ket 8
Foggia 8
Haiphong 8
Vienna 8
Belo Horizonte 7
Bisceglie 7
Bogotá 7
Brasília 7
Campinas 7
Chennai 7
Dearborn 7
Dublin 7
Düsseldorf 7
Inglewood 7
Porto Alegre 7
Totale 8.003
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 417
Sailing Across Contraception, Pregnancy, and Breastfeeding: The Complex Journey of Women with Cardiomyopathies 320
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis 282
Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation 267
Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X 248
Giant Cardiac Fibroma in a Completely Asymptomatic Teenager 239
No Reflow-phenomenon: from Current State of the Art to Future Perspectives 237
Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome 230
Impact of Predilation Before Transcatheter Aortic Valve Implantation with New-Generation Devices 226
A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient 216
Emergency coronary and peripheral arteries combined with percutaneous intervention in the elderly: success or therapeutic excess? 213
Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation 207
Prime time for the sweet spot in timing of coronary invasive approach in patients with non-ST elevation myocardial infarction 204
Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents 198
Remote ischemic preconditioning in isolated valve intervention. A pooled meta-analysis 197
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 191
Reverse takotsubo cardiomyopathy followed by left ventricle outflow tract obstruction: A dangerous relay race 188
How to Approach a Spontaneous Coronary Artery Dissection: An Up-To-Date 184
'Broken-heart' syndrome: ventricular septal perforation in a takotsubo cardiomyopathy 183
Cardiogenic Shock following Acute Myocardial Infarction: What's New? 181
Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction 179
STEMI and NSTEMI ACS in a 30-Year-Old Patient: An Extremely Rare Complication of a Left Atrial Myxoma. 179
Life-threatening acute myocardial infarction due to left main dissection during radiofrequency transcatheter ablation of atrial tachycardia 177
Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients 170
Correlation between endothelial dysfunction and myocardial damage in acute phase of Tako-Tsubo cardiomyopathy: brachial flow mediated dilation as a potential marker for assessment of patient with Tako-Tsubo. 166
Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk 166
Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy 157
Omega-3 fatty acids for the prevention of myocardial infarction and arrhythmias 153
Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure 142
Antithrombotic Therapy for Vascular Disease and Intervention: The Best Is Yet to Come? 133
Importance of clinical suspicion and multidisciplinary management for early diagnosis of a cardiac laminopathy patient: A case report 133
Aortic coarctation: guidelines mismatch across the ocean 123
Th2-dependent cytokine release in patients treated with coronary angioplasty 119
Aortic valve fibroelastoma presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA): a case report and review of the literature 118
Assessing the Best Prognostic Score for Transcatheter Aortic Valve Implantation (from the RISPEVA Registry) 115
Fractional flow reserve and intravascular scan as part of the coronary fistulas diagnostic process: Future perspectives 115
Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience 110
Inflammatory bowel disease and acute coronary syndromes: From pathogenesis to the fine line between bleeding and ischemic risk. 109
Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis? 107
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies 106
Alex Plus Versus Xience Drug-Eluting Stents for Percutaneous Coronary Intervention in Routine Clinical Practice: A Propensity Score-Matched Analysis 101
Prognostic value of 12-leads admission electrocardiogram in low-risk patients hospitalized for COVID-19 100
Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry 100
Corrigendum to "A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient" 99
Baseline, procedural and outcome features of patients undergoing transcatheter aortic valve implantation according to different body mass index categories 99
Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X 98
Sudden cardiac death secondary to demonstrated reperfusion ventricular fibrillation in a woman with Takotsubo cardiomyopathy 98
A Young Patient Presenting with Dilated Cardiomyopathy and Renal Infarction during Treatment with Isotretinoin: Mere Coincidence or Serious Side Effect of a Drug Commonly Used in Adolescence? 97
Percutaneous exclusion of ascending aorta pseudoaneurysms: still an interventional challenge? 94
Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥85 Years Versus Those <85 Years 94
Infiammazione Th17 dipendente e attivazione metallo-proteasica dopo angioplastica coronarica. 93
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]) 91
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 90
A concealed case of takotsubo syndrome as consequence of ab ingestis episode in a revascularized patient 89
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 88
Degenerative Severe Aortic Stenosis and Concomitant Coronary Artery Disease: What Is Changing in the Era of the "Transcatheter Revolution"? 84
TAVI-CT score to evaluate the anatomic risk in patients undergoing transcatheter aortic valve implantation 83
Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease: A Propensity Score-Adjusted Analysis From the RISPEVA Registry 79
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 78
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19 77
COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). 76
Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions 75
MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient 75
Anti-Inflammatory Therapy for Acute Coronary Syndromes: Is It Time for a Shift in the Treatment Paradigm? 74
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart 71
Transcatheter aortic valve implantation with Allegra: procedural and mid-term outcomes according to experience phase in a high-volume center 70
Clinical use of cangrelor: a real-world multicenter experience from South Italy 70
Percutaneous Edge-to-Edge Transcatheter Mitral Valve Repair: Current Indications and Future Perspectives. 70
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases 69
Transcatheter aortic valve implantation in patients with age ≤70 years: experience from two leading structural heart disease centers 68
Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes 64
Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study 64
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry 64
Role of pre-operative embolization in carotid body tumor surgery according to Shamblin classification: A systematic review and meta-analysis 64
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry 62
Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study 62
Minimally invasive approaches to primary cardiac tumors: A systematic review and meta-analysis 60
Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis 58
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 58
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry) 57
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 54
The best way to transcatheter aortic valve implantation: from standard to new approaches 53
Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway 53
Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score 52
Long-Term Follow-Up of Transcatheter Aortic Valve Implantation With Portico Versus Evolut Devices 52
Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation 52
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections 52
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis 51
Thrombocytopenia Complicating Transcatheter Aortic Valve Implantation: Differences Between Two New-Generation Devices 51
Unsupervised Machine Learning with Cluster Analysis in Patients Discharged after an Acute Coronary Syndrome: Insights from a 23,270-Patient Study 50
Underlying heart diseases and acute COVID-19 outcomes 50
Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis 48
Acute Hyperglycemia-Induced Injury in Myocardial Infarction 47
Percutaneous axillary vs femoral access for transcatheter aortic valve replacement: Insights from a 2164-patient study 46
Incidence and Predictors of Cerebrovascular Accidents in Patients Who Underwent Transcatheter Mitral Valve Repair With MitraClip 46
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry 45
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2) 44
Role of Indobufen in Coronary Artery Disease: The Story of a Neglected Drug. A Systematic Review 44
The Novel FlexNav Delivery System for Transcatheter Aortic Valve Implantation With the Portico Device: A Case Series 44
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry 44
Totale 11.546
Categoria #
all - tutte 38.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022192 22 4 2 4 10 26 16 11 14 18 25 40
2022/2023471 32 44 21 22 31 45 2 54 86 76 39 19
2023/2024319 21 50 22 26 35 80 8 13 10 12 9 33
2024/20251.925 93 20 80 130 78 148 289 176 98 107 221 485
2025/20267.790 514 224 3.014 469 475 291 547 210 641 542 192 671
2026/2027395 395 0 0 0 0 0 0 0 0 0 0 0
Totale 12.149